Surreal image of a colon road with a fragile liver tree.

Liver Cirrhosis & Colonoscopies: Are You at Risk?

Jordan Keane in Health & Wellness July 2025 • 4 min read.

"Understanding the Risks of Immediate Bleeding After Polypectomy"

Colorectal cancer is a major health concern, ranking as the third most common cancer worldwide and the second leading cause of cancer-related deaths. Colonoscopies have become a vital tool in screening for colorectal neoplasms, allowing for the removal of polyps before they become cancerous.

Colonoscopic polypectomy, the procedure to remove these polyps, is generally safe and effective in reducing both the incidence and mortality of colorectal cancer. However, like any medical procedure, it carries potential risks, including bleeding, perforation, and, in rare cases, death. Post-polypectomy bleeding (PPB) is among the most common complications.

For patients with liver cirrhosis, the risk landscape shifts. Liver cirrhosis, a chronic liver disease, can lead to thrombocytopenia (a reduced number of platelets in the blood) and other coagulation abnormalities, potentially increasing the risk of bleeding during invasive procedures. Despite this increased risk, the specific risk of PPB after colonoscopic polypectomy in patients with liver cirrhosis has not been well-defined – until now.

Decoding the Risks: Understanding Immediate Bleeding Post-Polypectomy

Surreal image of a colon road with a fragile liver tree.

A recent study published in the Yonsei Medical Journal sheds light on this critical issue. Researchers aimed to evaluate the risk of immediate post-polypectomy bleeding (IPPB) in patients with liver cirrhosis compared to those without liver disease. The study involved 89 patients with liver cirrhosis who underwent colonoscopic polypectomy between January 2006 and October 2012, alongside a control group of 348 individuals without liver disease.

The researchers meticulously analyzed various patient- and polyp-related factors to determine their influence on the risk of IPPB. These factors included:

Patient-related factors: Age, gender, body mass index (BMI), underlying diseases, use of antiplatelet therapy, and bowel preparation quality.
Polyp-related factors: Size, location, morphology (pedunculated or non-pedunculated), and histology (neoplastic or non-neoplastic).

Among the 89 patients with liver cirrhosis, the severity of their condition was classified according to the Child-Pugh scoring system, a widely used tool to assess the prognosis of chronic liver disease:

Child-Pugh Class A: 75 patients (84.3%)
Child-Pugh Class B: 10 patients (11.2%)
Child-Pugh Class C: 4 patients (4.5%)

Making Informed Decisions

While this study provides valuable insights, it's important to remember that it was conducted retrospectively at a single center. Further research, particularly randomized controlled trials, is needed to validate these findings and address the limitations of this study. It emphasizes the importance of personalized care and careful risk assessment when considering colonoscopies for patients with liver cirrhosis, particularly those with Child-Pugh class B or C.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is the primary concern when performing a colonoscopy on a patient with liver cirrhosis?

The primary concern is the increased risk of bleeding. Patients with liver cirrhosis often have thrombocytopenia (reduced platelets) and other coagulation abnormalities, which can make them more prone to bleeding during invasive procedures like colonoscopic polypectomy. This risk is further underscored by the study which highlights the need for careful risk assessment in these patients, especially those with advanced liver disease according to the Child-Pugh classification.

How does the Child-Pugh score influence the risk assessment for patients with liver cirrhosis undergoing a colonoscopy?

The Child-Pugh score is a crucial tool for assessing the severity of liver cirrhosis. The study categorized patients into Child-Pugh Classes A, B, and C. Patients in Classes B and C, representing more severe liver disease, are likely at a higher risk of complications like immediate post-polypectomy bleeding (IPPB). This scoring system helps doctors to make more informed decisions about performing colonoscopies and to tailor patient care based on the severity of their liver disease.

What are the key factors that were analyzed to determine the risk of immediate post-polypectomy bleeding (IPPB)?

The study analyzed various patient-related and polyp-related factors to determine their impact on the risk of IPPB. Patient-related factors included age, gender, BMI, underlying diseases, antiplatelet therapy use, and bowel preparation quality. Polyp-related factors encompassed size, location, morphology (pedunculated or non-pedunculated), and histology (neoplastic or non-neoplastic). These factors were assessed to understand which elements contribute to increased bleeding risk in patients with liver cirrhosis undergoing colonoscopic polypectomy.

Why are colonoscopies and colonoscopic polypectomies considered important, and what are their associated risks?

Colonoscopies are vital for screening for colorectal neoplasms, and colonoscopic polypectomy allows for the removal of polyps before they turn cancerous, thus reducing both the incidence and mortality of colorectal cancer. However, colonoscopic polypectomy carries potential risks, including bleeding, perforation, and, in rare cases, death. Post-polypectomy bleeding (PPB) is a common complication, and the risk is heightened in patients with liver cirrhosis due to their underlying condition.

Can you explain the limitations of the study and the need for further research regarding colonoscopies in patients with liver cirrhosis?

The study was conducted retrospectively at a single center, which is a significant limitation. Retrospective studies analyze data that has already been collected, which might not capture all relevant factors or be subject to biases. Further research, specifically randomized controlled trials, is needed to validate the findings and address these limitations. Such trials would allow for more rigorous testing and validation of risk factors and management strategies for patients with liver cirrhosis undergoing colonoscopies, leading to more personalized and safer care, especially for those with Child-Pugh class B or C.